David Rescott

Stock Analyst at Baird

(3.70)
# 808
Out of 4,711 analysts
41
Total ratings
57.58%
Success rate
6.5%
Average return

Stocks Rated by David Rescott

Medtronic
Nov 20, 2024
Maintains: Neutral
Price Target: $96$93
Current: $81.03
Upside: +14.77%
Penumbra
Oct 31, 2024
Maintains: Outperform
Price Target: $244$248
Current: $242.54
Upside: +2.25%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $107$109
Current: $98.22
Upside: +10.98%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $66$72
Current: $47.59
Upside: +51.29%
Inari Medical
Oct 29, 2024
Maintains: Outperform
Price Target: $66$67
Current: $55.45
Upside: +20.83%
Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73$68
Current: $74.81
Upside: -9.10%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $503$565
Current: $524.43
Upside: +7.74%
Boston Scientific
Jul 25, 2024
Maintains: Outperform
Price Target: $90$91
Current: $88.95
Upside: +2.30%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25$26
Current: $13.25
Upside: +96.23%